Financhill
Buy
60

THC Quote, Financials, Valuation and Earnings

Last price:
$212.14
Seasonality move :
12.69%
Day range:
$209.52 - $217.71
52-week range:
$109.82 - $222.82
Dividend yield:
0%
P/E ratio:
14.49x
P/S ratio:
0.94x
P/B ratio:
4.63x
Volume:
968.1K
Avg. volume:
1.1M
1-year change:
49.6%
Market cap:
$18.6B
Revenue:
$20.7B
EPS (TTM):
$14.59

Analysts' Opinion

  • Consensus Rating
    Tenet Healthcare Corp. has received a consensus rating of Buy. The company's average rating is a Buy based on 14 Buy ratings, 2 Hold ratings, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $234.33, Tenet Healthcare Corp. has an estimated upside of 10.88% from its current price of $211.34.
  • Price Target Downside
    According to analysts, the lowest downside price target is $167.00 representing 20.98% downside risk from its current price of $211.34.

Fair Value

  • According to the consensus of 16 analysts, Tenet Healthcare Corp. has 10.88% upside to fair value with a price target of $234.33 per share.

THC vs. S&P 500

  • Over the past 5 trading days, Tenet Healthcare Corp. has underperformed the S&P 500 by -3.27% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • Tenet Healthcare Corp. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Tenet Healthcare Corp. has grown year-over-year revenues for 2 quarters straight. In the most recent quarter Tenet Healthcare Corp. reported revenues of $5.3B.

Earnings Growth

  • Tenet Healthcare Corp. earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Tenet Healthcare Corp. reported earnings per share of $3.86.
Enterprise value:
33.5B
EV / Invested capital:
1.53x
Price / LTM sales:
0.94x
EV / EBIT:
10.00x
EV / Revenue:
1.61x
PEG ratio (5yr expected):
0.01x
EV / Free cash flow:
22.28x
Price / Operating cash flow:
13.06x
Enterprise value / EBITDA:
8.02x
Gross Profit (TTM):
$3.3B
Return On Assets:
7.88%
Net Income Margin (TTM):
11.01%
Return On Equity:
27.14%
Return On Invested Capital:
10.53%
Operating Margin:
15.45%
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Income Statement
Revenue $20.2B $21B $20.9B $5.1B $5.3B
Gross Profit $2.3B $2.9B $3.3B $707M $817M
Operating Income $2.3B $2.9B $3.3B $707M $817M
EBITDA $3.2B $3.7B $4.2B $916M $1B
Diluted EPS $4.45 $31.25 $14.59 $4.88 $3.86
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Balance Sheet
Current Assets $6.9B $6B $6.4B $8.8B $7.8B
Total Assets $25.9B $27.1B $27.6B $29.4B $29.4B
Current Liabilities $5.4B $4.3B $4.4B $5.5B $4.6B
Total Liabilities $22.2B $22.5B $22.4B $21.3B $20.7B
Total Equity $3.7B $4.6B $5.2B $8.1B $8.7B
Total Debt $14.1B $15.1B $15B $12.9B $13.2B
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Cash Flow Statement
Cash Flow Operations $2B $3.2B $2.5B $1B $1.1B
Cash From Investing -$1.1B $3.3B -$1.4B $631M -$385M
Cash From Financing -$1.1B -$3.5B -$2.2B -$462M -$323M
Free Cash Flow $1.1B $2.4B $1.5B $829M $778M
THC
Sector
Market Cap
$18.6B
$28.4M
Price % of 52-Week High
94.85%
50.35%
Dividend Yield
0%
0%
Shareholder Yield
6.31%
-1.32%
1-Year Price Total Return
49.6%
-22.19%
Beta (5-Year)
1.444
0.521
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years

Technicals

8-day SMA
Sell
Level $212.58
200-day SMA
Buy
Level $167.72
Bollinger Bands (100)
Buy
Level 171.97 - 206.43
Chaikin Money Flow
Buy
Level 59.4M
20-day SMA
Buy
Level $203.38
Relative Strength Index (RSI14)
Buy
Level 56.47
ADX Line
Buy
Level 19.79
Williams %R
Neutral
Level -31.3482
50-day SMA
Buy
Level $202.60
MACD (12, 26)
Buy
Level 3.73
25-day Aroon Oscillator
Buy
Level 28
On Balance Volume
Neutral
Level 122.6M

Financial Scores

Sell
Altman Z-Score (Annual)
Level (1.6844)
Sell
CA Score (Annual)
Level (-1.5561)
Buy
Beneish M-Score (Annual)
Level (-2.2647)
Buy
Momentum Score
Level (9)
Buy
Ohlson Score
Level (-0.8311)
Buy
Piotroski F Score (Annual)
Level (7)
Buy
Quality Ratio Score
Level (5)
Buy
Fundamental Score
Level (7)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Tenet Healthcare Corp. engages in the provision of healthcare services. It operates through the Hospital Operations and Ambulatory Care segments. The Hospital Operations segment is composed of acute care hospitals, ancillary outpatient facilities, urgent care centers, micro hospitals and physician practices. The Ambulatory Care segment includes the operations of the USPI joint venture and the company's nine Aspen facilities in the United Kingdom. The company was founded in 1969 and is headquartered in Dallas, TX.

Stock Forecast FAQ

In the current month, THC has received 14 Buy ratings 2 Hold ratings, and 0 Sell ratings. The THC average analyst price target in the past 3 months is $234.33.

  • Where Will Tenet Healthcare Corp. Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Tenet Healthcare Corp. share price will rise to $234.33 per share over the next 12 months.

  • What Do Analysts Say About Tenet Healthcare Corp.?

    Analysts are divided on their view about Tenet Healthcare Corp. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Tenet Healthcare Corp. is a Sell and believe this share price will drop from its current level to $167.00.

  • What Is Tenet Healthcare Corp.'s Price Target?

    The price target for Tenet Healthcare Corp. over the next 1-year time period is forecast to be $234.33 according to 16 Wall Street analysts, 14 of them rate the stock a Buy, 0 rate the stock a Sell, and 2 analysts rate the stock a Hold.

  • Is THC A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Tenet Healthcare Corp. is a Buy. 14 of 16 analysts rate the stock a Buy at this time.

  • How Can I Buy Shares Of THC?

    You can purchase shares of Tenet Healthcare Corp. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Tenet Healthcare Corp. shares.

  • What Is The Tenet Healthcare Corp. Share Price Today?

    Tenet Healthcare Corp. was last trading at $212.14 per share. This represents the most recent stock quote for Tenet Healthcare Corp.. Yesterday, Tenet Healthcare Corp. closed at $211.34 per share.

  • How To Buy Tenet Healthcare Corp. Stock Online?

    In order to purchase Tenet Healthcare Corp. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Amazon an AI Stock?
Is Amazon an AI Stock?

With the market starting to look skittish on pure-play AI…

Google Vs NVIDIA Stock: Which Is Best?
Google Vs NVIDIA Stock: Which Is Best?

Alphabet (NASDAQ:GOOGL) and NVIDIA (NASDAQ:NVIDIA) are two of the market’s…

How High Could NVIDIA Stock Go?
How High Could NVIDIA Stock Go?

NVIDIA (NASDAQ:NVDA) has been one of the best stocks to…

Stock Ideas

Buy
51
Is NVDA Stock a Buy?

Market Cap: $4.4T
P/E Ratio: 61x

Buy
65
Is AAPL Stock a Buy?

Market Cap: $4.2T
P/E Ratio: 38x

Buy
69
Is GOOG Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 40x

Alerts

Sell
47
PSTG alert for Dec 4

Pure Storage, Inc. [PSTG] is up 5.05% over the past day.

Sell
41
SMX alert for Dec 4

SMX (Security Matters) Plc [SMX] is up 154.74% over the past day.

Sell
43
HY alert for Dec 4

Hyster-Yale, Inc. [HY] is up 1.92% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock